| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0553580|ewing sarcoma |
| Sentences | 1 |
| PubMedID- 24624321 | Published data from a randomized trial showing improved five-year event-free survival (69%) after the addition of etoposide and ifex to a standard regimen in patients with nonmetastatic ewing sarcoma, primitive neuroectodermal tumor of bone, and primitive sarcoma of bone. |
Page: 1